Inventiva Dividend 2024

Inventiva Dividend

0 EUR

Inventiva Dividend yield

Ticker

IVA.PA

ISIN

FR0013233012

WKN

A2DLV9

How much dividend does Inventiva 2024 pay?

According to the latest status from May 2024, Inventiva paid a total of 0 EUR per share in dividends within the last 12 months. With the current Inventiva price of 3.29 EUR, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.

=

Historical Inventiva Dividends

A dividend is paid times per year. Last year, the payout months were and .

PaydateDividend

Is the Inventiva Dividend Safe?

Inventiva has been increasing the dividend for 0 years.

Over the past 10 years, Inventiva has increased it by an annual 0 %.

Over a five-year period, the distribution increased by 0%.

Analysts expect a Dividend Cut of -100% for the current fiscal year.

Dividend Details

Understanding Inventiva's Dividend Distributions

Inventiva’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Inventiva's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Inventiva's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Inventiva’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Inventiva Aktienanalyse

What does Inventiva do?

Inventiva SA is a biopharmaceutical company based in France that specializes in the development of novel therapies for various diseases. The company was founded in 2002 by Pierre Broqua and Frédéric Cren to develop innovative drugs based on research on the human genome. Inventiva's business model is to develop a pipeline of drug candidates and either sell them or bring them into partnerships with other companies. The company has built a broad portfolio of patents and license agreements that allow it to develop a variety of products. Inventiva's research and development focuses on three key areas: fibrosis, oncology, and autoimmune diseases. In these areas, the company has several product candidates in various stages of clinical development. Inventiva's products include Lanifibranor, a drug for the treatment of fatty liver disease, which is currently in Phase III trials. Additionally, the company has several compounds in its oncology pipeline, including IVA337, IVA336, and IVA339, all of which have shown promising results in preclinical studies. In the field of autoimmune diseases, Inventiva is working on a compound called ABBV-157, which is being developed in collaboration with Abbvie. This compound is intended to help reduce inflammation in patients with rheumatoid arthritis and psoriasis. Overall, Inventiva has made significant progress in recent years and has achieved important milestones in the development of its products. The company has also entered into several partnerships with major pharmaceutical and biotech companies to bring its products to market. In 2020, Inventiva took the next important step in its growth strategy by announcing a merger with American company AbbVie. The acquisition is expected to accelerate the development and commercialization of Inventiva's products and provide the company with a strong partner in the international market. However, Inventiva has not limited itself to drug development. The company has also developed a range of services to support other companies in the development of new drugs. These include laboratory services, protein purification and analysis, cell culture, and more, offered through their own contract research organization (CRO) unit. In summary, Inventiva is an emerging company with a strong portfolio of products and services. The company has done excellent work in developing new medical technologies in recent years and is likely to have even more success in the future with the acquisition by AbbVie. Inventiva is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Frequently Asked Questions about Inventiva Stock

How much dividend does Inventiva pay?

Over the past 12 months, Inventiva paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Inventiva is expected to pay a dividend of 0 EUR.

What is the dividend yield of Inventiva?

The current dividend yield of Inventiva is .

When does Inventiva pay dividends?

Inventiva pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Inventiva?

Inventiva paid dividends every year for the past 0 years.

What is the dividend of Inventiva?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Inventiva located?

Inventiva is assigned to the 'Health' sector.

Wann musste ich die Aktien von Inventiva kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Inventiva from 5/27/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 5/27/2024.

When did Inventiva pay the last dividend?

The last dividend was paid out on 5/27/2024.

What was the dividend of Inventiva in the year 2023?

In the year 2023, Inventiva distributed 0 EUR as dividends.

In which currency does Inventiva pay out the dividend?

The dividends of Inventiva are distributed in EUR.

Andere Kennzahlen von Inventiva

Our stock analysis for Inventiva Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Inventiva Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.